| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 35,271 | 35,078 | 31,908 | 33,486 | | Cost of Revenue | 31,556 | 32,429 | 29,601 | 30,817 | | | Gross Profit | 3,716 | 2,648 | 2,307 | 2,669 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,761 | 2,242 | 1,612 | 2,499 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 4,041 | 4,920 | 3,154 | 3,898 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,087) | (4,513) | (2,460) | (3,728) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 32 | 124 | 169 | 65 | | Earnings Before Interest And Taxes | (1,985) | (4,308) | (2,162) | (3,330) | | Interest Expense | 4,628 | 4,016 | 4,178 | 4,820 | | Income Before Tax | (6,613) | (8,325) | (6,341) | (8,150) | | Income Tax Expense | (268) | (434) | 50 | (237) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,346) | (7,890) | (6,391) | (7,913) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,346) | (7,890) | (6,391) | (7,913) | | Preferred Stock And Other Adjustments |
-
|
-
| (604) | (40) | | | Net Income Applicable To Common Shares | ($6,346) | ($7,890) | ($6,994) | ($7,953) |
|
0.02% Nasdaq 0.00%
Income Statement
